LNWWM
RDY icon

Laird Norton Wetherby Wealth Management’s Dr. Reddy's Laboratories RDY Stock Holding History

Laird Norton Wetherby Wealth Management’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$2.69M Sell
192,336
-1,468
-0.8% -$21.1K 0.11% 178
2025
Q2 		$2.91M Buy
+193,804
New +$2.77M 0.13% 154
2024
Q4 		$3.16M Sell
200,098
-9,677
-5% -$145K 0.15% 115
2024
Q3 		$3.33M Buy
209,775
+5,060
+2% +$81.4K 0.15% 118
2024
Q2 		$3.12M Buy
204,715
+24,055
+13% +$345K 0.15% 127
2024
Q1 		$2.65M Buy
180,660
+5,145
+3% +$75.1K 0.13% 160
2023
Q4 		$2.44M Buy
175,515
+3,655
+2% +$48.9K 0.13% 161
2023
Q3 		$2.3M Buy
171,860
+1,595
+0.9% +$21.6K 0.13% 152
2023
Q2 		$2.15M Sell
170,265
-2,220
-1% -$25.9K 0.12% 177
2023
Q1 		$1.96M Buy
172,485
+35,575
+26% +$384K 0.11% 184
2022
Q4 		$1.42M Buy
136,910
+8,050
+6% +$86.8K 0.09% 246
2022
Q3 		$1.35M Buy
128,860
+120
+0.1% +$1.28K 0.1% 223
2022
Q2 		$1.43M Buy
128,740
+30,565
+31% +$332K 0.1% 214
2022
Q1 		$1.09M Buy
98,175
+14,700
+18% +$167K 0.06% 290
2021
Q4 		$1.09M Buy
83,475
+215
+0.3% +$2.71K 0.06% 300
2021
Q3 		$1.08M Buy
83,260
+360
+0.4% +$4.8K 0.07% 276
2021
Q2 		$1.22M Buy
82,900
+985
+1% +$13.8K 0.07% 254
2021
Q1 		$1M Sell
81,915
-370
-0.4% -$4.75K 0.08% 252
2020
Q4 		$1.17M Sell
82,285
-855
-1% -$11.5K 0.08% 238
2020
Q3 		$1.16M Sell
83,140
-4,060
-5% -$48.4K 0.1% 195
2020
Q2 		$924K Sell
87,200
-3,415
-4% -$34.7K 0.09% 226
2020
Q1 		$731K Buy
90,615
+8,335
+10% +$69.5K 0.08% 237
2019
Q4 		$668K Buy
82,280
+1,750
+2% +$13.8K 0.07% 324
2019
Q3 		$610K Buy
80,530
+6,010
+8% +$44.7K 0.06% 342
2019
Q2 		$559K Buy
74,520
+2,610
+4% +$20.5K 0.06% 356
2019
Q1 		$583K Buy
71,910
+5,815
+9% +$44.2K 0.07% 326
2018
Q4 		$499K Buy
66,095
+8,405
+15% +$59.1K 0.07% 330
2018
Q3 		$399K Buy
57,690
+7,700
+15% +$51.5K 0.05% 419
2018
Q2 		$322K Buy
49,990
+1,385
+3% +$8.74K 0.04% 452
2018
Q1 		$318K Sell
48,605
-8,955
-16% -$62.8K 0.04% 460
2017
Q4 		$433K Buy
57,560
+5,615
+11% +$40.4K 0.06% 384
2017
Q3 		$371K Buy
51,945
+9,710
+23% +$69.8K 0.06% 404
2017
Q2 		$356K Sell
42,235
-200
-0.5% -$1.63K 0.06% 393
2017
Q1 		$340K Buy
42,435
+3,555
+9% +$30.7K 0.06% 392
2016
Q4 		$352K Buy
38,880
+1,830
+5% +$17K 0.07% 363
2016
Q3 		$343K Sell
37,050
-545
-1% -$5.2K 0.07% 343
2016
Q2 		$385K Buy
37,595
+5,090
+16% +$46.6K 0.09% 291
2016
Q1 		$294K Buy
32,505
+2,275
+8% +$20.3K 0.07% 336
2015
Q4 		$279K Sell
30,230
-4,320
-13% -$47.3K 0.07% 340
2015
Q3 		$442K Buy
34,550
+3,335
+11% +$41.4K 0.11% 219
2015
Q2 		$345K Buy
31,215
+2,375
+8% +$26.2K 0.08% 279
2015
Q1 		$329K Buy
28,840
+370
+1% +$3.92K 0.08% 299
2014
Q4 		$287K Buy
28,470
+1,000
+4% +$10.5K 0.07% 317
2014
Q3 		$289K Sell
27,470
-535
-2% -$5.03K 0.08% 307
2014
Q2 		$242K Sell
28,005
-2,635
-9% -$22.2K 0.07% 348
2014
Q1 		$269K Buy
30,640
+110
+0.4% +$957 0.08% 317
2013
Q4 		$251K Buy
30,530
+1,075
+4% +$8.51K 0.07% 335
2013
Q3 		$223K Sell
29,455
-1,265
-4% -$9.2K 0.07% 349
2013
Q2 		$232K Buy
+30,720
New +$224K 0.08% 308

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Laird Norton Wetherby Wealth Management's RDY Position: Q3 2025 in Review

Laird Norton Wetherby Wealth Management reduced its Dr. Reddy's Laboratories (RDY) stake by 0.76% in Q3 2025, selling an estimated $21.1K and leaving 192,336 shares worth $2.69M. The position accounts for 0.11% of the portfolio, ranked #178.

Laird Norton Wetherby Wealth Management first reported a position in RDY in Q2 2013 and has held it in 49 quarters since. The position peaked at $3.33M in Q3 2024. 228 funds tracked by Wall St. Rank hold RDY as of Q3 2025.

  • Laird Norton Wetherby Wealth Management held 192,336 shares of Dr. Reddy's Laboratories worth $2.69M as of Q3 2025.
  • Laird Norton Wetherby Wealth Management sold 1,468 Dr. Reddy's Laboratories shares in Q3 2025, an estimated $21.1K.
  • Dr. Reddy's Laboratories made up 0.11% of Laird Norton Wetherby Wealth Management's portfolio in Q3 2025, its #178 holding.
  • Laird Norton Wetherby Wealth Management first reported a position in Dr. Reddy's Laboratories in Q2 2013 and has held it in 49 quarters since.
  • Laird Norton Wetherby Wealth Management's Dr. Reddy's Laboratories position peaked at $3.33M in Q3 2024.
  • 228 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q3 2025.

Based on Laird Norton Wetherby Wealth Management's 13F filing for Q3 2025, filed 14 Nov 2025.